Mirae Asset Global ETFs Holdings’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
VCM
SF
VPM
Mirae Asset Global ETFs Holdings's AVXL Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its Anavex Life Sciences (AVXL) stake by 3.9% in Q1 2026, buying an estimated $8.12K and bringing the position to 49,802 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2492.
Mirae Asset Global ETFs Holdings first reported a position in AVXL in Q2 2024 and has held it in 8 quarters since. The position peaked at $491K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 49,802 shares of Anavex Life Sciences worth $150K as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 1,875 Anavex Life Sciences shares in Q1 2026, an estimated $8.12K.
- Anavex Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2492 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Anavex Life Sciences in Q2 2024 and has held it in 8 quarters since.
- Mirae Asset Global ETFs Holdings's Anavex Life Sciences position peaked at $491K in Q4 2024.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.